Shares of Kenvue (KVUE) took off Monday morning on indications 澳洲幸运5官方开奖结果体彩网:activist investor Starboard Value has taken a large stake in the consumer health produ🧸cts maker.

The Wall Street Journal and Reuters report it's unclear how big of an investment the 澳洲幸运5官方开奖结果体彩网:hedge fund has made in the maker of Tylenol, Band-Aids, and Listerine.The Journal, which first reported the news, said that Starboard has taken a "sizable stake" and wants the company to make changes to boost its stock price, while Reuters pointed out that the share price has fallen 18% since Kenvue 澳洲幸运5官方开奖结果体彩网:began trading last year after it was spun off of Johnson & Johnson (JNJ).

The Journal noted that Starboard founder and 澳洲幸运5官方开奖结果体彩网:Chief Executive Officer (CEO) Jeff Smith is expected to outlin𝄹e the firm's pl𝔉ans for Kenvue at tomorrow's 13D Monitor Active-Passive Investor Summit in New York.

Reuters added that Smith will also speak at the conference about Starboard's plans for Pfizer (PFE) after it recently made an approximately 澳洲幸运5官方开奖结果体彩网:$1 billion stake in the drug maker.

Investopedia has reached out to both ꧑Starboard and Kenvue for comment.

Kenvue shares had been roughly flat year-to-date before rising 6% soon after markets opened Monday.